The 40-week postinduction studies strongly indicate that deletion of PRL2 in the PTEN HET mice imparts a phenotype to the HSC and myeloid populations, within the BM, blood, and spleen, that is more characteristic of WT than that of AML seen in their PTEN HET counterparts. Here, PTP4A2 is linked to acute myeloid leukemia.